Your browser doesn't support javascript.
loading
Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway.
Saad, Muhammed A; Ahmed, Maha A E; Elbadawy, Norhan N; Abdelkader, Noha F.
Afiliación
  • Saad MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; School of Pharmacy, New Giza University, Giza, Egypt.
  • Ahmed MAE; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th October city, Giza, Egypt.
  • Elbadawy NN; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th October city, Giza, Egypt.
  • Abdelkader NF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: noha.fawzy@pharma.cu.edu.eg.
Prog Neuropsychopharmacol Biol Psychiatry ; 111: 110368, 2021 12 20.
Article en En | MEDLINE | ID: mdl-34087391
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares / Enfermedad de Huntington / Fármacos Neuroprotectores / Serina-Treonina Quinasas TOR / Ivabradina Límite: Animals Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Egipto
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares / Enfermedad de Huntington / Fármacos Neuroprotectores / Serina-Treonina Quinasas TOR / Ivabradina Límite: Animals Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Egipto